BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38718283)

  • 21. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).
    Généreux P; Cohen DJ; Williams MR; Mack M; Kodali SK; Svensson LG; Kirtane AJ; Xu K; McAndrew TC; Makkar R; Smith CR; Leon MB
    J Am Coll Cardiol; 2014 Mar; 63(11):1100-9. PubMed ID: 24291283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute left main stem coronary occlusion following transcatheter aortic valve replacement in a patient without recognized coronary obstruction risk factors: a case report.
    Spina R; Khalique O; George I; Nazif T
    Eur Heart J Case Rep; 2018 Dec; 2(4):yty112. PubMed ID: 31020188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants and outcomes of acute transcatheter valve-in-valve therapy or embolization: a study of multiple valve implants in the U.S. PARTNER trial (Placement of AoRTic TraNscathetER Valve Trial Edwards SAPIEN Transcatheter Heart Valve).
    Makkar RR; Jilaihawi H; Chakravarty T; Fontana GP; Kapadia S; Babaliaros V; Cheng W; Thourani VH; Bavaria J; Svensson L; Kodali S; Shiota T; Siegel R; Tuzcu EM; Xu K; Hahn RT; Herrmann HC; Reisman M; Whisenant B; Lim S; Beohar N; Mack M; Teirstein P; Rihal C; Douglas PS; Blackstone E; Pichard A; Webb JG; Leon MB
    J Am Coll Cardiol; 2013 Jul; 62(5):418-30. PubMed ID: 23684680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The first transapical transcatheter aortic valve-in-valve implantation using the J-valve system into a failed biophysio aortic prosthesis in a patient with high risk of coronary obstruction.
    Ye J; Lee AJ; Blanke P; Webb J
    Catheter Cardiovasc Interv; 2018 Nov; 92(6):1209-1214. PubMed ID: 29602249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary Access After TAVR.
    Ochiai T; Chakravarty T; Yoon SH; Kaewkes D; Flint N; Patel V; Mahani S; Tiwana R; Sekhon N; Nakamura M; Cheng W; Makkar R
    JACC Cardiovasc Interv; 2020 Mar; 13(6):693-705. PubMed ID: 32192689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First-in-Human Dedicated Leaflet Splitting Device for Prevention of Coronary Obstruction in Transcatheter Aortic Valve Replacement.
    Dvir D; Leon MB; Abdel-Wahab M; Unbehaun A; Kodali S; Tchetche D; Pibarot P; Leipsic J; Blanke P; Gerckens U; Manoharan G; Harari E; Hellou E; Wolak A; Ben-Assa E; Jubeh R; Shuvy M; Koifman E; Klein C; Kempfert J
    JACC Cardiovasc Interv; 2023 Jan; 16(1):94-102. PubMed ID: 36599593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcatheter aortic valve thrombosis: the relation between hypo-attenuated leaflet thickening, abnormal valve haemodynamics, and stroke.
    Vollema EM; Kong WKF; Katsanos S; Kamperidis V; van Rosendael PJ; van der Kley F; de Weger A; Ajmone Marsan N; Delgado V; Bax JJ
    Eur Heart J; 2017 Apr; 38(16):1207-1217. PubMed ID: 28369242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leaflet Mechanical Properties of Carpentier-Edwards Perimount Magna Pericardial Aortic Bioprostheses.
    Kuang H; Xuan Y; Lu M; Mookhoek A; Wisneski AD; Guccione JM; Ge L; Tseng EE
    J Heart Valve Dis; 2017 Jan; 26(1):81-89. PubMed ID: 28544835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Real-world experience with concomitant or staged transcatheter aortic and mitral valve replacements using balloon-expandable valves.
    Zajarias A; Kodali S; McCabe JM; Eng MH; Babaliaros V
    Catheter Cardiovasc Interv; 2022 Nov; 100(5):890-900. PubMed ID: 35971750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of repeat transcatheter aortic valve replacement for the treatment of transcatheter prosthesis dysfunction.
    Faroux L; Alperi A; Muntané-Carol G; Rodes-Cabau J
    Expert Rev Med Devices; 2020 Dec; 17(12):1303-1310. PubMed ID: 33196328
    [No Abstract]   [Full Text] [Related]  

  • 31. Computed tomography analysis of coronary ostia location following valve-in-valve transcatheter aortic valve replacement with the ACURATE neo valve: Implications for coronary access.
    Khokhar AA; Laricchia A; Ponticelli F; Kim WK; Gallo F; Regazzoli D; Toselli M; Sticchi A; Ruggiero R; Cereda A; Zlahoda-Huzior A; Fisicaro A; Gardi I; Mangieri A; Reimers B; Dudek D; Colombo A; Giannini F
    Catheter Cardiovasc Interv; 2021 Sep; 98(3):595-604. PubMed ID: 33586278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study.
    Chakravarty T; Søndergaard L; Friedman J; De Backer O; Berman D; Kofoed KF; Jilaihawi H; Shiota T; Abramowitz Y; Jørgensen TH; Rami T; Israr S; Fontana G; de Knegt M; Fuchs A; Lyden P; Trento A; Bhatt DL; Leon MB; Makkar RR; ;
    Lancet; 2017 Jun; 389(10087):2383-2392. PubMed ID: 28330690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac Computed Tomography Angiography Anatomical Characterization of Patients Screened for a Dedicated Transfemoral Transcatheter Valve System for Primary Aortic Regurgitation.
    Gogia S; Vahl TP; Thourani VH; Yadav PK; George I; Kodali SK; Hamid N; Ranard L; Chen T; Matsumura M; Maehara A; Treede H; Baldus S; Daniels D; Sheridan BC; Zahr F; Russo MJ; McCabe JM; Chetcuti SJ; Leon MB; Makkar RR; Khalique OK
    Struct Heart; 2023 May; 7(3):100164. PubMed ID: 37273856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computed tomography (CT) assessment of the membranous septal anatomy prior to transcatheter aortic valve replacement (TAVR) with the balloon-expandable SAPIEN 3 valve.
    Oestreich BA; Mbai M; Gurevich S; Nijjar PS; Adabag S; Bertog S; Kelly R; Garcia S
    Cardiovasc Revasc Med; 2018; 19(5 Pt B):626-631. PubMed ID: 29352699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracardiac echocardiography-guided transcatheter aortic valve replacement.
    Kadakia MB; Silvestry FE; Herrmann HC
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):497-501. PubMed ID: 24478152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aortic valve leaflet disruption techniques in transcatheter aortic valve replacement.
    Shin B; Li D; Liu H
    J Geriatr Cardiol; 2022 Dec; 19(12):990-994. PubMed ID: 36632205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CT annulus sizing prior to transcatheter aortic valve replacement (TAVR): evaluation of free-breathing versus breath-holding acquisition.
    Cour A; Burel J; Garnier M; Durand E; Demeyere M; Dacher JN
    Eur Radiol; 2023 Dec; 33(12):8521-8527. PubMed ID: 37470824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Outcomes After Transcatheter vs Surgical Aortic Valve Replacement Among Patients at Intermediate Operative Risk With a History of Coronary Artery Bypass Graft Surgery: A Post Hoc Analysis of the SURTAVI Randomized Clinical Trial.
    Reardon MJ; Heijmen RH; Van Mieghem NM; Williams MR; Yakubov SJ; Watson D; Kleiman NS; Conte J; Chawla A; Hockmuth D; Petrossian G; Robinson N; Kappetein AP; Li S; Popma JJ
    JAMA Cardiol; 2019 Aug; 4(8):810-814. PubMed ID: 31215985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Standardized methodology for transfemoral transcatheter aortic valve replacement with the Edwards Sapien XT valve under fluoroscopy guidance.
    Kasel AM; Shivaraju A; Schneider S; Krapf S; Oertel F; Burgdorf C; Ott I; Sumer C; Kastrati A; von Scheidt W; Thilo C
    J Invasive Cardiol; 2014 Sep; 26(9):451-61. PubMed ID: 25198489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First-in-man transfemoral transcatheter aortic valve replacement with the 29 mm Edwards SAPIEN XT valve.
    Freeman M; Rodés-Cabau J; Urena M; DeLarochelliere R; Dumont E; Masson JB; Willson AB; Binder RK; Toggweiler S; Leipsic J; Wood DA; Webb JG
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):664-70. PubMed ID: 22744829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.